Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Noninvasive Monitoring of Cerebral Blood Flow Autoregulation

NCT05170295 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.

NCT NCT05170295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05170295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Noninvasive Monitoring of Cerebral Blood Flow Autoregulation
Lead sponsor
Ochsner Health System
Phase
Observational
Overall status
Completed
Start date
April 18, 2018
Completion date
April 28, 2021
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral edema, intracranial pressure increase